Effectiveness of estrogen and its derivatives over dexamethasone in the treatment of COVID-19

References

• Akbarzadeh-Khiavi, M., Torabi, M., Rahbarnia, L., & Safary, A. (2022). Baricitinib combination therapy: A narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection. Infection, 50(2), 295–308. https://doi.org/10.1007/s15010-021-01730-6
   PubMed Web of Science ®Google Scholar
• Al-Kuraishy, H. M., Al-Gareeb, A. I., Faidah, H., Al-Maiahy, T. J., Cruz-Martins, N., & Batiha, G. E.-S. (2021). The looming effects of estrogen in Covid-19: A rocky rollout. Frontiers in Nutrition, 8, 649128. https://doi.org/10.3389/fnut.2021.649128
   PubMed Web of Science ®Google Scholar
• Azam, F., Eid, E. E. M., & Almutairi, A. (2021). Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation. Journal of Molecular Structure, 1246, 131124. https://doi.org/10.1016/j.molstruc.2021.131124
   PubMed Web of Science ®Google Scholar
• Baker, L., Meldrum, K. K., Wang, M., Sankula, R., Vanam, R., Raiesdana, A., Tsai, B., Hile, K., Brown, J. W., & Meldrum, D. R. (2003). The role of estrogen in cardiovascular disease. The Journal of Surgical Research, 115(2), 325–344. https://doi.org/10.1016/s0022-4804(03)00215-4
   PubMed Web of Science ®Google Scholar
• Bennink, H. J. T. C., Foidart, J.-M., & Debruyne, F. M. J. (2021). Treatment of serious COVID-19 with testosterone suppression and high-dose estrogen therapy. European Urology, 80(4), 523–525. https://doi.org/10.1016/j.eururo.2021.06.024
   PubMed Web of Science ®Google Scholar
• Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012). Quantifying the chemical beauty of drugs. Nature Chemistry, 4(2), 90–98. https://doi.org/10.1038/nchem.1243
   PubMed Web of Science ®Google Scholar
• Bowers, K. J., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., Moraes, M. A., & Sacerdoti, F. D. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the 2006 ACM/IEEE Conference on Supercomputing, 84–es.
   Google Scholar
• Chang, L., Yan, Y., & Wang, L. (2020). Coronavirus disease 2019: Coronaviruses and blood safety. Transfusion Medicine Reviews, 34(2), 75–80. https://doi.org/10.1016/j.tmrv.2020.02.003
   PubMed Web of Science ®Google Scholar
• Chen, Y., & Li, L. (2020). SARS-CoV-2: Virus dynamics and host response. The Lancet. Infectious Diseases, 20(5), 515–516. https://doi.org/10.1016/S1473-3099(20)30235-8
   PubMed Web of Science ®Google Scholar
• Coelingh Bennink, H. J. T., Heegaard, A.-M., Visser, M., Holinka, C. F., & Christiansen, C. (2008). Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model. Climacteric, 11(suppl 1), 2–14. https://doi.org/10.1080/13697130701798692
   PubMed Web of Science ®Google Scholar
• Cooper, D. B., Patel, P., & Mahdy, H. (2017). Oral contraceptive pills. https://www.ncbi.nlm.nih.gov/books/NBK430882/
   Google Scholar
• Costeira, R., Lee, K. A., Murray, B., Christiansen, C., Castillo-Fernandez, J., Ni Lochlainn, M., Capdevila Pujol, J., Macfarlane, H., Kenny, L. C., Buchan, I., Wolf, J., Rymer, J., Ourselin, S., Steves, C. J., Spector, T. D., Newson, L. R., & Bell, J. T. (2021). Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study. PloS One, 16(9), e0257051. https://doi.org/10.1371/journal.pone.0257051
   PubMed Web of Science ®Google Scholar
• Council, N. R. (2014). Physicochemical properties and environmental fate. In A Framework to Guide Selection of Chemical Alternatives. National Academies Press (US).
   Google Scholar
• Cui, J., Shen, Y., & Li, R. (2013). Estrogen synthesis and signaling pathways during aging: From periphery to brain. Trends in Molecular Medicine, 19(3), 197–209. https://doi.org/10.1016/j.molmed.2012.12.007
   PubMed Web of Science ®Google Scholar
• Daina, A., & Zoete, V. (2016). A boiled‐egg to predict gastrointestinal absorption and brain penetration of small molecules. Chem Med Chem. 11(11), 1117–1121. https://doi.org/10.1002/cmdc.201600182
   Google Scholar
• Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7(1), 1–13. https://doi.org/10.1038/srep42717
   PubMed Web of Science ®Google Scholar
• Deroo, B. J., & Korach, K. S. (2006). Estrogen receptors and human disease. The Journal of Clinical Investigation, 116(3), 561–570. https://doi.org/10.1172/JCI27987
   PubMed Web of Science ®Google Scholar
• Ertl, P., & Schuffenhauer, A. (2009). Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. Journal of Cheminformatics, 1(1), 1–11. https://doi.org/10.1186/1758-2946-1-8
   PubMedGoogle Scholar
• Fakhar, Z., Khan, S., AlOmar, S. Y., Alkhuriji, A., & Ahmad, A. (2021). ABBV-744 as a potential inhibitor of SARS-CoV-2 main protease enzyme against COVID-19. Scientific Reports, 11(1), 1–15. https://doi.org/10.1038/s41598-020-79918-3
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006). Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein − ligand complexes. Journal of Medicinal Chemistry, 49(21), 6177–6196. https://doi.org/10.1021/jm051256o
   PubMed Web of Science ®Google Scholar
• Fruzzetti, F., Fidecicchi, T., Montt Guevara, M. M., & Simoncini, T. (2021). Estetrol: A new choice for contraception. Journal of Clinical Medicine, 10(23), 5625. https://doi.org/10.3390/jcm10235625
   PubMed Web of Science ®Google Scholar
• Götte, M. (2021). Remdesivir for the treatment of Covid-19: The value of biochemical studies. Current Opinion in Virology, 49, 81–85. https://doi.org/10.1016/j.coviro.2021.04.014
   PubMed Web of Science ®Google Scholar
• Grob, S. (2021). Slovakia. Molinspiration cheminformatics free web services. Available https://www. Molinspiration.Com (Accessed on 15 January 2022).
   Google Scholar
• Halgren, T. A. (2009). Identifying and characterizing binding sites and assessing druggability. Journal of Chemical Information and Modeling, 49(2), 377–389. https://doi.org/10.1021/ci800324m
   PubMed Web of Science ®Google Scholar
• Islam, T., Hasan, M., Rahman, M. S., & Islam, M. R. (2022). Comparative evaluation of authorized drugs for treating Covid‐19 patients. Health Science Reports, 5(4), e671. https://doi.org/10.1002/hsr2.671
   PubMedGoogle Scholar
• Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022). Mechanisms of SARS-CoV-2 entry into cells. Nature Reviews Molecular Cell Biology, 23(1), 3–20. https://doi.org/10.1038/s41580-021-00418-x
   PubMed Web of Science ®Google Scholar
• Jacobson, M. P., Pincus, D. L., Rapp, C. S., Day, T. J. F., Honig, B., Shaw, D. E., & Friesner, R. A. (2004). A hierarchical approach to all‐atom protein loop prediction. Proteins, 55(2), 351–367. https://doi.org/10.1002/prot.10613
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Kaludjerovic, J., & Ward, W. E. (2012). The interplay between estrogen and fetal adrenal cortex. Journal of Nutrition and Metabolism, 2012, 1–12. https://doi.org/10.1155/2012/837901
   Google Scholar
• Khelfaoui, H., Harkati, D., & Saleh, B. A. (2021). Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2. Journal of Biomolecular Structure and Dynamics, 39(18), 7246–7262. https://doi.org/10.1080/07391102.2020.1803967
   PubMed Web of Science ®Google Scholar
• Kime, D. E. (1987). Fundamentals of comparative vertebrate endocrinology. In Phillips J. G., Chester-Jones I, Ingleton PM (Ed.), General and comparative endocrinology. (Vol. 68, Issue 3, p. 494). Springer Science & Business Media. https://doi.org/10.1016/0016-6480(87)90090-6
   Google Scholar
• Kneller, D. W., Phillips, G., O'Neill, H. M., Jedrzejczak, R., Stols, L., Langan, P., Joachimiak, A., Coates, L., & Kovalevsky, A. (2020). Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography. Nature Communications, 11(1), 3202. https://doi.org/10.1038/s41467-020-16954-7
   PubMed Web of Science ®Google Scholar
• Kocks, J., Kerkhof, M., Scherpenisse, J., van de Maat, A., van Geer-Postmus, I., Le Rütte, T., Schaart, J., Gans, R. O. B., & Kerstjens, H. A. M. (2022). A potential harmful effect of dexamethasone in non-severe COVID-19: Results from the COPPER-pilot study. ERJ Open Research, 8(2), 00129–2022. https://doi.org/10.1183/23120541.00129-2022
   PubMedGoogle Scholar
• Koellhoffer, E. C., & McCullough, L. D. (2013). The effects of estrogen in ischemic stroke. Translational Stroke Research, 4(4), 390–401. https://doi.org/10.1007/s12975-012-0230-5
   PubMed Web of Science ®Google Scholar
• Kokate, A., Li, X., & Jasti, B. (2008). Effect of drug lipophilicity and ionization on permeability across the buccal mucosa: A technical note. AAPS PharmSciTech, 9(2), 501–504. https://doi.org/10.1208/s12249-008-9071-7
   PubMed Web of Science ®Google Scholar
• Ledford, H. (2020). Coronavirus breakthrough: Dexamethasone is first drug shown to save lives. Nature, 582(7813), 469–470. https://doi.org/10.1038/d41586-020-01824-5
   PubMed Web of Science ®Google Scholar
• Li, R., Cui, J., & Shen, Y. (2014). Brain sex matters: Estrogen in cognition and Alzheimer’s disease. Molecular and Cellular Endocrinology, 389(1-2), 13–21. https://doi.org/10.1016/j.mce.2013.12.018
   PubMed Web of Science ®Google Scholar
• López-Medrano, F., Pérez-Jacoiste Asín, M. A., Fernández-Ruiz, M., Carretero, O., Lalueza, A., Maestro de la Calle, G., Caro, J. M., de la Calle, C., Catalán, M., García-García, R., Martínez-López, J., Origüen, J., Ripoll, M., San Juan, R., Trujillo, H., Sevillano, Á., Gutiérrez, E., de Miguel, B., Aguilar, F., … Aguado, J. M, H12O Immunomodulation Therapy for COVID-19 Group. (2021). Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study. International Journal of Infectious Diseases: IJID: Official Publication of the International Society for Infectious Diseases, 105, 487–494. https://doi.org/10.1016/j.ijid.2021.02.099
   PubMed Web of Science ®Google Scholar
• Mattos-Silva, P., Felix, N. S., Silva, P. L., Robba, C., Battaglini, D., Pelosi, P., Rocco, P. R. M., & Cruz, F. F. (2020). Pros and cons of corticosteroid therapy for COVID-19 patients. Respiratory Physiology & Neurobiology, 280, 103492. https://doi.org/10.1016/j.resp.2020.103492
   PubMed Web of Science ®Google Scholar
• Mehmood, Q., Chahal, P., Patel, P., Upadhyay, P., Nawaz, A., Mukhopadhyay, D., Corriero, A. C., Mukherjee, D., Kurmi, U. G., & Balkore, H. A. (2021). Sex hormones as an emerging weapon to combat COVID-19. OSF Preprints, 27(April)
   Google Scholar
• MoHFW | Home. (2023). Retrieved March 20, 2023, from https://www.mohfw.gov.in/
   Google Scholar
• Narayanan, A., Narwal, M., Majowicz, S. A., Varricchio, C., Toner, S. A., Ballatore, C., Brancale, A., Murakami, K. S., & Jose, J. (2022). Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay. Communications Biology, 5(1), 169. https://doi.org/10.1038/s42003-022-03090-9
   PubMed Web of Science ®Google Scholar
• O’Connell, M. B. (1995). Pharmacokinetic and pharmacologic variation between different estrogen products. The Journal of Clinical Pharmacology, 35(9S), 18S–24S.
   PubMed Web of Science ®Google Scholar
• Owen, C., Robinson, S., Christofides, A., & Sehn, L. H. (2022). A Canadian Perspective: Monoclonal antibodies for pre-and post-exposure protection from COVID-19 in vulnerable patients with hematological malignancies. Current Oncology (Toronto, Ont.), 29(6), 3940–3949. https://doi.org/10.3390/curroncol29060315
   PubMed Web of Science ®Google Scholar
• Patel, S. K., Saikumar, G., Rana, J., Dhama, J., Yatoo, M. I., Tiwari, R., Rodriguez-Morales, A. J., & Dhama, K. (2020). Dexamethasone: A boon for critically ill COVID-19 patients? Travel Medicine and Infectious Disease, 37, 101844. https://doi.org/10.1016/j.tmaid.2020.101844
   PubMed Web of Science ®Google Scholar
• Pirhadi, R., Talaulikar, V. S., Onwude, J., & Manyonda, I. (2020). Could estrogen protect women from COVID-19? Journal of Clinical Medicine Research, 12(10), 634–639. https://doi.org/10.14740/jocmr4303
   PubMedGoogle Scholar
• Price, G., & Patel, D. A. (2021). Drug bioavailability. In StatPearls [Internet]. StatPearls Publishing.
   Google Scholar
• Ramírez-de-Arellano, A., Gutiérrez-Franco, J., Sierra-Diaz, E., & Pereira-Suárez, A. L. (2021). The role of estradiol in the immune response against COVID-19. Hormones (Athens, Greece), 20(4), 657–667. https://doi.org/10.1007/s42000-021-00300-7
   PubMedGoogle Scholar
• Rodriguez-Garcia, J. L., Sanchez-Nievas, G., Arevalo-Serrano, J., Garcia-Gomez, C., Jimenez-Vizuete, J. M., & Martinez-Alfaro, E. (2021). Baricitinib improves respiratory function in patients treated with corticosteroids for SARS-CoV-2 pneumonia: An observational cohort study. Rheumatology (Oxford, England), 60(1), 399–407. https://doi.org/10.1093/rheumatology/keaa587
   PubMed Web of Science ®Google Scholar
• Rut, W., Groborz, K., Zhang, L., Sun, X., Zmudzinski, M., Pawlik, B., Wang, X., Jochmans, D., Neyts, J., Młynarski, W., Hilgenfeld, R., & Drag, M. (2021). SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nature Chemical Biology, 17(2), 222–228. https://doi.org/10.1038/s41589-020-00689-z
   PubMed Web of Science ®Google Scholar
• Sander, T. (2001). OSIRIS property explorer. Organic Chemistry Portal.
   Google Scholar
• Sanyaolu, A., Okorie, C., Marinkovic, A., Patidar, R., Younis, K., Desai, P., Hosein, Z., Padda, I., Mangat, J., & Altaf, M. (2020). Comorbidity and its impact on patients with COVID-19. SN Comprehensive Clinical Medicine, 2(8), 1069–1076. https://doi.org/10.1007/s42399-020-00363-4
   PubMedGoogle Scholar
• Sharma, P., & Shanavas, A. (2021). Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: A brief computational analysis. Journal of Biomolecular Structure & Dynamics, 39(15), 5819–5830. https://doi.org/10.1080/07391102.2020.1794970
   PubMed Web of Science ®Google Scholar
• Simpson, E., Rubin, G., Clyne, C., Robertson, K., O'Donnell, L., Jones, M., & Davis, S. (2000). The role of local estrogen biosynthesis in males and females. Trends in Endocrinology and Metabolism: TEM, 11(5), 184–188. https://doi.org/10.1016/s1043-2760(00)00254-x
   PubMed Web of Science ®Google Scholar
• Soma, M. (2022). Current therapeutics effective against SARS-CoV-2 omicron sub-variants. Scholars Bulletin, 8(8), 238–247. https://doi.org/10.36348/sb.2022.v08i08.002
   Google Scholar
• Spoorenberg, S. M. C., Deneer, V. H. M., Grutters, J. C., Pulles, A. E., Voorn, G. P., Rijkers, G. T., Bos, W. J. W., & van de Garde, E. M. W. (2014). Pharmacokinetics of oral vs. intravenous dexamethasone in patients hospitalized with community‐acquired pneumonia. British Journal of Clinical Pharmacology, 78(1), 78–83. https://doi.org/10.1111/bcp.12295
   PubMed Web of Science ®Google Scholar
• Suba, Z. (2020). Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients: Prevention and therapy of COVID-19. Journal of Pharmacy & Pharmaceutical Sciences: A Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques, 23(1), 75–85. https://doi.org/10.18433/jpps31069
   PubMed Web of Science ®Google Scholar
• Talal, N., Dauphinee, M., & Ahmed, S. A. (1992). CD5 B Cells in Autoimmunity. Annals of the New York Academy of Sciences, 651(1), 551–556. https://doi.org/10.1111/j.1749-6632.1992.tb24661.x
   PubMedGoogle Scholar
• Van den Eynde, E., Gasch, O., Oliva, J. C., Prieto, E., Calzado, S., Gomila, A., Machado, M. L., Falgueras, L., Ortonobes, S., Morón, A., Capilla, S., Navarro, G., Oristrell, J., Cervantes, M., & Navarro, M. (2021). Corticosteroids and tocilizumab reduce in-hospital mortality in severe COVID-19 pneumonia: A retrospective study in a Spanish hospital. Infectious Diseases (London, England), 53(4), 291–302. https://doi.org/10.1080/23744235.2021.1884286
   PubMed Web of Science ®Google Scholar
• Wanounou, M., Caraco, Y., Levy, R. H., Bialer, M., & Perucca, E. (2022). Clinically relevant interactions between ritonavir-boosted nirmatrelvir and concomitant antiseizure medications: Implications for the management of COVID-19 in patients with epilepsy. Clinical Pharmacokinetics, 61(9), 1219–1236. https://doi.org/10.1007/s40262-022-01152-z
   PubMed Web of Science ®Google Scholar
• WHO Coronavirus (COVID-19) Dashboard. (2023). WHO Coronavirus (COVID-19) Dashboard With Vaccination Data Retrieved March 20, 2023, from https://covid19.who.int/
   Google Scholar
• Yetmar, Z. A., Bhaimia, E., & Razonable, R. R. (2022). Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients. Current Opinion in Organ Transplantation, 27(4), 269–276. https://doi.org/10.1097/MOT.0000000000000981
   PubMed Web of Science ®Google Scholar